DRUG

linalool

5 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for linalool

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
PD-L1 colitis 0.269 Mid partial evidence none

Pancreatic cancer 4

Mediator Outcome Score Tier Lit. status Trial
PD-L1 type 2 autoimmune pancreatitis 0.269 Mid novel signal none
PD-L1 poor differentiation 0.269 Mid novel signal none
PD-L1 immunosuppression 0.208 Mid novel signal none
PD-L1 lymph node metastasis 0.208 Mid novel signal none

Clinical trials

15 registered trials for linalool

Source: ClinicalTrials.gov